206 related articles for article (PubMed ID: 31510016)
1. Expression of Oncogenic Drivers in 3D Cell Culture Depends on Nuclear ATP Synthesis by NUDT5.
Pickup KE; Pardow F; Carbonell-Caballero J; Lioutas A; Villanueva-Cañas JL; Wright RHG; Beato M
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31510016
[TBL] [Abstract][Full Text] [Related]
2. The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling.
Zhang H; Zhang LQ; Yang CC; Li J; Tian XY; Li DN; Cui J; Cai JP
PLoS One; 2021; 16(2):e0245876. PubMed ID: 33571243
[TBL] [Abstract][Full Text] [Related]
3. Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.
Page BDG; Valerie NCK; Wright RHG; Wallner O; Isaksson R; Carter M; Rudd SG; Loseva O; Jemth AS; Almlöf I; Font-Mateu J; Llona-Minguez S; Baranczewski P; Jeppsson F; Homan E; Almqvist H; Axelsson H; Regmi S; Gustavsson AL; Lundbäck T; Scobie M; Strömberg K; Stenmark P; Beato M; Helleday T
Nat Commun; 2018 Jan; 9(1):250. PubMed ID: 29343827
[TBL] [Abstract][Full Text] [Related]
4. The high expression of MTH1 and NUDT5 promotes tumor metastasis and indicates a poor prognosis in patients with non-small-cell lung cancer.
Li DN; Yang CC; Li J; Ou Yang QG; Zeng LT; Fan GQ; Liu TH; Tian XY; Wang JJ; Zhang H; Dai DP; Cui J; Cai JP
Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118895. PubMed ID: 33096144
[TBL] [Abstract][Full Text] [Related]
5. Identification of promising inhibitors against breast cancer disease by targeting NUDIX hydrolase 5 (NUDT5) biomolecule.
Almansour NM
J Biomol Struct Dyn; 2023 Dec; ():1-12. PubMed ID: 38063166
[TBL] [Abstract][Full Text] [Related]
6. Molecular docking based virtual screening of the breast cancer target NUDT5.
Sultana R; Islam M; Haque MA; Evamoni FZ; Imran ZM; Khanom J; Munim MA
Bioinformation; 2019; 15(11):784-789. PubMed ID: 31902977
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of a new member of the Nudix hydrolases from human and mouse.
Yang H; Slupska MM; Wei YF; Tai JH; Luther WM; Xia YR; Shih DM; Chiang JH; Baikalov C; Fitz-Gibbon S; Phan IT; Conrad A; Miller JH
J Biol Chem; 2000 Mar; 275(12):8844-53. PubMed ID: 10722730
[TBL] [Abstract][Full Text] [Related]
8. Activation of NUDT5, an ADP-ribose pyrophosphatase, by nitric oxide-mediated ADP-ribosylation.
Yu HN; Song EK; Yoo SM; Lee YR; Han MK; Yim CY; Kwak JY; Kim JS
Biochem Biophys Res Commun; 2007 Mar; 354(3):764-8. PubMed ID: 17261271
[TBL] [Abstract][Full Text] [Related]
9. Role of the NUDT Enzymes in Breast Cancer.
Wright RHG; Beato M
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668737
[TBL] [Abstract][Full Text] [Related]
10. The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma.
Wang JJ; Liu TH; Li J; Li DN; Tian XY; Ouyang QG; Cai JP
PeerJ; 2020; 8():e9195. PubMed ID: 32518727
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of oxidized guanine nucleotide and ADP sugar by human NUDT5 protein.
Ito R; Sekiguchi M; Setoyama D; Nakatsu Y; Yamagata Y; Hayakawa H
J Biochem; 2011 Jun; 149(6):731-8. PubMed ID: 21389046
[TBL] [Abstract][Full Text] [Related]
12. Silencing of Nudix type 5 represses proliferation and invasion and enhances chemosensitivity of gastric carcinoma cells by affecting the AKT/GSK-3β/β-catenin pathway.
Tan D; Zhang Y
Toxicol Appl Pharmacol; 2022 Apr; 441():115968. PubMed ID: 35247377
[TBL] [Abstract][Full Text] [Related]
13. Identification of NUDT5 Inhibitors From Approved Drugs.
Tong XY; Liao X; Gao M; Lv BM; Chen XH; Chu XY; Zhang QY; Zhang HY
Front Mol Biosci; 2020; 7():44. PubMed ID: 32300600
[TBL] [Abstract][Full Text] [Related]
14. Lowered nudix type 5 (NUDT5) expression leads to cell cycle retardation in HeLa cells.
Zhang LQ; Dai DP; Gan W; Takagi Y; Hayakawa H; Sekiguchi M; Cai JP
Mol Cell Biochem; 2012 Apr; 363(1-2):377-84. PubMed ID: 22200976
[TBL] [Abstract][Full Text] [Related]
15. Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
Asaduzzaman M; Constantinou S; Min H; Gallon J; Lin ML; Singh P; Raguz S; Ali S; Shousha S; Coombes RC; Lam EW; Hu Y; Yagüe E
Breast Cancer Res Treat; 2017 Jun; 163(3):461-474. PubMed ID: 28341962
[TBL] [Abstract][Full Text] [Related]
16. NUDT5 as a novel drug target and prognostic biomarker for ER-positive breast cancer.
Tong XY; Quan Y; Zhang HY
Drug Discov Today; 2021 Mar; 26(3):620-625. PubMed ID: 33276127
[TBL] [Abstract][Full Text] [Related]
17. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein nmb Is Exposed on the Surface of Dormant Breast Cancer Cells and Induces Stem Cell-like Properties.
Chen C; Okita Y; Watanabe Y; Abe F; Fikry MA; Ichikawa Y; Suzuki H; Shibuya A; Kato M
Cancer Res; 2018 Nov; 78(22):6424-6435. PubMed ID: 30224376
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of ADP-ribose hydrolysis by human NUDT5 from structural and kinetic studies.
Zha M; Guo Q; Zhang Y; Yu B; Ou Y; Zhong C; Ding J
J Mol Biol; 2008 Jun; 379(3):568-78. PubMed ID: 18462755
[TBL] [Abstract][Full Text] [Related]
20. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
